Pharmacy Medical Policy Updates
The following Pharmacy Medical Policy programs have been updated Dec. 15, 2022:
Effective Jan. 15, 2023:
- Biologic Immunomodulators
Effective Feb. 1, 2023:
- ACA Copay Waiver
- Natpara
- Retinoids
- Antidepressant
- Urea Cycle Disorders
- Factor VIII and VWF
- Isturisa
- SA Oncology
- Coverage Exception
Many of our pharmacy medical policies are maintained through our pharmacy benefit manager, Prime Therapeutics.
To find pharmacy medical policies specific to a medication list, please select a medication list at the bottom of our prior authorization page of our website, https://www.bcbsks.com/providers/precertification-prior-authorization.
If you have any questions regarding this newsletter, please contact your BCBSKS provider representative/consultant.